Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: March 21, 2011
Last updated: July 8, 2013
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 8, 2013